SFX by Ex Libris Inc.

Title:	Crystal Structure of the TAO2 Kinase Domain
Source:	Structure [0969-2126] Zhou, Tianjun yr:2004

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Byeon, In-Ja J. "NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity." Nature communications 4.1 (2013): 1890-1890.
description	2.	Siu, K. "Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F." Nature communications 4.11 (2013): 2593-2593.
description	3.	Eggimann, Gianluigi L. "Modeling helical proteins using residual dipolar couplings, sparse long-range distance constraints and a simple residue-based force field." Theoretical Chemistry accounts 132.10 (2013): 1-16.
description	4.	McDougle, Rebecca M. "D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B." Virology (2013).
description	5.	Antipenko, A. "Structure of the semaphorin-3A receptor binding module." Neuron 39.4 (2003): 589-598.
description	6.	Okulicz, Jason F. "Influence of the Timing of Antiretroviral Therapy on the Potential for Normalization of Immune Status in Human Immunodeficiency Virus 1-Infected Individuals." JAMA internal medicine 175.1 (2014): 88-99.
description	7.	Mitra, M. "Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties." Nucleic acids research (2013): 1095-1110.
description	8.	Mittag, T. "From Sequence and Forces to Structure, Function, and Evolution of Intrinsically Disordered Proteins." Structure 21.9 (2013): 1492-1499.
description	9.	Nowarski, R. "APOBEC3 Cytidine Deaminases in Double-Strand DNA Break Repair and Cancer Promotion." Cancer research 73.12 (2013): 3494-3498.
description	10.	Dings, Ruud P M P. "Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer." Investigational new drugs 31.5 (2013): 1142-1150.
description	11.	Nellas, Ricky B. "Exploring the discrepancies between experiment, theory, and simulation for the homogeneous gas-to-liquid nucleation of 1-pentanol." The Journal of chemical physics 132.16 (2010): 164517-.
description	12.	Janssen, Bert J C J. "Structural basis of semaphorin-plexin signalling." Nature 467.7319 (2010): 1118-1122.
description	13.	Adams, R H H. "The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing." The EMBO journal 16.20 (1997): 6077-86.
description	14.	Iadecola, C.. "Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease." Stroke 37.6 (2006): 1578-1581.
description	15.	Mariani, R. "Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif." Cell 114.1 (2003): 21-31.
description	16.	Friedler, A. "Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides." Bioorganic & medicinal chemistry 21.12 (2013): 3523-32.
description	17.	Lundgren, Jens D. "Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection." The New England journal of medicine 373.9 (2015): 795-807.
description	18.	Katz, Ingrid T. "Factors Associated With Lack of Viral Suppression at Delivery Among Highly Active Antiretroviral Therapy-Naive Women With HIV: A Cohort Study." Annals of Internal Medicine 162.2 (2015): 90-9.
description	19.	Thomas, B. "Expanding the scope of oxime ligation: facile synthesis of large cyclopeptide-based glycodendrimers." Chemical communications (London. 1996) 49.92 (2013): 10796-8.
description	20.	Alexander, Brian M. "Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2." Neuro-oncology 15.8 (2013): 972-8.